News

Teva Receives FDA Approval for First Generic Lexapro

03/14/2012

The US Food and Drug Administration (FDA) granted the first generic Lexapro (escitalopram tablets) approval to treat adults with depression and generalized anxiety disorder. The drug, manufactured by Teva Pharmaceutical Industries, will come in 5 mg, 10 mg, and 20 mg strengths. Teva will have generic exclusivity for 180 days. Lexapro, manufactured by Forest Laboratories, had $2.59 billion in retail sales in 2010, according to data from Medco Health Solutions. The drug patent protection expired today. The FDA's news release is available at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm296006.htm?source=govdelivery Read Teva's news release at https://www.tevapharm.com/Media/News/Pages/2012/1672770.aspx -Tim Casey

Current Issue

October/November/December Volume 21, Issue 4, First Report Managed Care

Current Issue

Issue Archive

What's Trending?

News

Understanding the Link Between bDMARD Initiation, Switching With Mood Disorders

10/02/2020

Researchers found a positive association between the use of antidepressant and anxiolytic medication with both the introduction and switching of bDMARDs.

Researchers found a positive...

10/02/2020

First Report Managed Care

News

Medicare wants pharmacists out of Plan D decision-making process

12/15/2010

First Report Managed Care

News Connection

Travel, Wait Times Cost $89 Billion Annually for Health Care Service

03/20/2019

According to survey data from the Bureau of Labor Statistics’ American Wait Time Use Survey, spanning 2006 through 2017, travel and wait times were highest for health care services, ranked above legal services, personal care, vehicular...

According to survey data from...

03/20/2019

First Report Managed Care

News

Even When Employed, Health Care A Challenge

02/23/2012

First Report Managed Care

News

Limited HIV Resources Best Invested in Community-Based Prevention Education

10/16/2015

Researchers suggest that funds for HIV treatment and prevention should focus first on effective, inexpensive community-based education for HIV prevention efforts.

Researchers suggest that funds...

10/16/2015

First Report Managed Care

Video Insights

Videos

Minimally Invasive Solutions for Lumbar Disc Herniation

01/07/2025

Ferdinand Formoso , DO;

In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...

In this interview, Ferdinand...

01/07/2025

First Report Managed Care

Videos

Navigating Biosimilar Adoption: Lessons from Global Markets and Clinical Practices

12/20/2024

Michael Kolodziej , MD;

In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...

In this interview, Michael...

12/20/2024

First Report Managed Care

Videos

12/18/2024

Michael Kolodziej , MD;

In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...

In this interview, Michael...

12/18/2024

First Report Managed Care

Videos

Navigating Biosimilar Integration: Cost Savings, Coverage, and Future Strategies for Payers

12/10/2024

John Hennessy , MBA;

John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...

John Hennessy, MBA, discusses...

12/10/2024

First Report Managed Care

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton , MD;

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Martin Dietrich , MD, PhD;

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Jordan Bazinsky ;

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Teva Receives FDA Approval for First Generic Lexapro

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products